|
|||||||||||||||||
|
|
|||||||||||||||||
|
|||||||||||||||||
|
|
|||||||||||||||||
February 26, 2008 Contacts: Ellen Ternes, 301-405-4621 or univcomm@umd.edu Chemistry Breakthrough Could Lead to Better Drug Design
While molecular containers occur in nature, those in products like Febreze and pharmaceuticals are synthetic, and don't measure up to the natural version for strength and stability. With molecular containers offering great possibilities in nanotechnology for things like dispensing drugs and medical treatments, scientists have been looking for new ways to create stronger, more stable molecular containers, but have had limited success. Now, Lyle Isaacs, University of Maryland associate professor of chemistry, and an international research team have made a breakthrough in creating stronger synthetic molecular containers that not only could open new doors for new medical and commercial applications, but can be produced on the scale needed for real world applications. "This really is a milestone," says Isaacs. "Our results get around some of the big problems encountered in today's synthetic molecular containers and rival those found in nature." The team's findings were published in the Dec. 17, 2007 online issue of the Proceedings of the National Academies of Science . Tough Containers
"Molecular containers are naturally occurring and important to biology," Isaacs says. "A protein-ligand pair known as Avidin-Biotin is widely used in biological and technological applications because the interaction functions as an irreversible tight glue." Scientists have developed synthetic molecular containers, called cyclodextrins, which have been successful and important for pharmaceutical and industrial uses. But Isaacs says, they don't match the natural Avidin-Biotin in strength and flexibility. "Cyclodextrins can be leaky. Also, they come in only three sizes, which limits how you can use them. "Scientists have been trying to come up with synthetic molecular containers that perform the same way as Avidin-Biotin," says Isaacs, "but have had a very hard time because of a general phenomenon known as enthalpy-entropy compensation that is thought to act universally. We found a synthetic host-guest pair that binds as tightly as Avidin-Biotin and does so by overcoming the compensatory enthalpy-entropy relationship." Stuck Like Glue That synthetic host-guest pair is called cucurbit[7]uril, or CB[7], a synthetic compound that may be even better than nature's version. "They go so far beyond cyclodextrins. We showed that CB[7] acts as a glue that's very strong but flexible. The CB[7] guest pair is stuck together with the same affinity as the Avidin-Biotin system. CB[7] can be produced in hundreds of grams and it's all done in water, which is much more environmentally friendly." CB[7] can be produced to accommodate different types of cargo: peptides to modify the body's rate of metabolism; fluorescent molecules to enhance their brightness and extend their lifetime in applications like imaging and lasers; and neurotransmitters for medical diagnosis.
Simin Liu, a former postdoctoral fellow in the Isaacs lab at Maryland , was also a member of the research team. The research is funded in part by grants from the National Science Foundation.
Lyle Isaacs went to college planning to become a doctor. Discovering he wanted to be a chemist instead was an "Aha!" moment for him. "When I took organic chemistry in pre-med, that's when knew I didn't want to be a doctor any more, I wanted to study chemistry. When I was a kid, I had loved playing with Legos, seeing how things fit together. I could envision how things go together chemically. I think of myself as an architect of molecules."
| |||||||||||||||||